Suscribirse

Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism - 27/09/18

Doi : 10.1016/j.amjmed.2018.04.037 
Benjamin Brenner, MD a, b, , Behnood Bikdeli, MD c, d, e, Inna Tzoran, MD a, b, Olga Madridano, MD, PhD f, Raquel López-Reyes, MD, PhD g, José María Suriñach, MD, PhD h, Ángeles Blanco-Molina, MD, PhD i, Antonella Tufano, MD, PhD j, Juan José López Núñez, MD k, Javier Trujillo-Santos, MD, PhD l, Manuel Monreal, MD, PhD k, 1

for the RIETE Investigators1

  A full list of the RIETE investigators is provided in the Appendix.

a Rambam Health Care Campus, Haifa, Israel 
b Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel 
c Division of Cardiology, Department of Medicine, Columbia University Medical Center/ New York-Presbyterian Hospital, New York, NY 
d Center for Outcomes Research & Evaluation (CORE), Yale University School of Medicine, New Haven, Conn 
e Cardiovascular Research Foundation (CRF), New York, NY 
f Department of Internal Medicine, Hospital Universitario Infanta Sofía, Madrid, Spain 
g Department of Pneumonology, Hospital Universitari i Politècnic La Fe, Valencia, Spain 
h Department of Internal Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain 
i Department of Internal Medicine, Hospital Universitario Reina Sofía, Córdoba, Spain 
j Regional Reference Centre for Coagulation Disorders, Department of Clinical Medicine and Surgery, Federico II, University Hospital, Naples, Italy 
k Department of Internal Medicine, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain 
l Department of Internal Medicine, Hospital General Universitario Santa Lucía, Murcia, Spain 

Requests for reprints should be addressed to Benjamin Brenner, MD, Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, 8, Ha'Aliya Street, Haifa 3109601, Israel.Department of Hematology and Bone Marrow TransplantationRambam Health Care Campus8, Ha'Aliya StreetHaifa3109601Israel

Resumen

Arterial events are a major cause of death in cancer patients with venous thrombosis.
Arterial events occur early after venous thrombosis in cancer patients.
The risk of arterial events should be considered in this clinical setting.

El texto completo de este artículo está disponible en PDF.

Abstract

Background

Venous thromboembolism is common in patients with malignancies, affecting up to 10% of this patient population. The association between arterial ischemic events and venous thromboembolism also has been established. However, the influence of arterial ischemic events on outcomes in cancer patients with venous thromboembolism has not been fully determined.

Methods

The current study analyzed clinical characteristics, time course, risk factors, incidence and severity of venous thromboembolism recurrences, arterial ischemic events and major bleeding in 5717 patients with active cancer and venous thromboembolism recruited into RIETE (multi-center prospective registry of patients with objectively confirmed venous thromboembolism).

Results

During the anticoagulation course (median 7.3 months), 499 (8.7%) patients developed venous thromboembolism recurrences, 63 (1.1%) developed arterial events, and 346 (6.1%) suffered from major bleeding. Overall, major bleeding and arterial events appeared earlier (median 35 and 36 days, respectively) than venous thromboembolism recurrences (median 97 days). Thirty-day mortality rates after each event were: 20% after recurrent pulmonary embolism, 13% after recurrent deep vein thrombosis, 41% after major bleeding, 40% after myocardial infarction, 64% after ischemic stroke, and 83% after lower limb amputation. Bleeding was the leading cause of death (67 fatal bleeds), whereas cumulative mortality due to arterial ischemic events (n = 27) was similar to that related to pulmonary embolism recurrences (n = 26).

Conclusions

In this study, arterial ischemic events and major bleeding appeared early after venous thromboembolism in patients with active cancer and were among frequent causes of their deaths. The risk and severity of arterial events need to be considered in this clinical setting.

El texto completo de este artículo está disponible en PDF.

Keywords : Arterial ischemic events, Bleeding, Cancer, Venous thromboembolism


Esquema


 Funding: B Bikdeli is supported by the National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), through grant number T32 HL007854. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
 Conflict of Interest: The authors declare no conflicts of interest relevant to this submission.
 Authorship: B Brenner designed research, interpreted the data, wrote the paper, and approved the final version of the paper; B Bikdeli designed research, interpreted the data, wrote the paper, and approved the final version of the paper; IT recruited patients, performed research, interpreted the data, and approved the final version of the paper; OM recruited patients, performed research, and approved the final version of the paper; RL-R recruited patients, performed research, and approved the final version of the paper; JMS recruited patients, performed research, and approved the final version of the paper; ÁB-M recruited patients, performed research, and approved the final version of the paper; AT recruited patients, performed research, and approved the final version of the paper; JJLN recruited patients, performed research, and approved the final version of the paper; JT-S recruited patients, performed research, interpreted the data, and approved the final version of the paper; and MM recruited patients, designed research, interpreted the data, wrote the paper, approved the final version of the paper, and obtained funding.


© 2018  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 131 - N° 9

P. 1095-1103 - septembre 2018 Regresar al número
Artículo precedente Artículo precedente
  • Twenty-Five-Year (1986-2011) Trends in the Incidence and Death Rates of Stroke Complicating Acute Myocardial Infarction
  • Essa Hariri, Mayra Tisminetzky, Darleen Lessard, Jorge Yarzebski, Joel Gore, Robert Goldberg
| Artículo siguiente Artículo siguiente
  • Importance of Early Insertion of Inferior Vena Cava Filters in Unstable Patients with Acute Pulmonary Embolism
  • Paul D. Stein, Fadi Matta, Frank R. Lawrence, Mary J. Hughes

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.